Arora Manan, Chase Henry, Bertocci Michele A, Skeba Alexander S, Eckstrand Kristen, Bebko Genna, Aslam Haris A, Raeder Robert, Graur Simona, Benjamin Osasumwen, Wang Yiming, Stiffler Richelle S, Phillips Mary L
Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania.
JAMA Psychiatry. 2025 Mar 1;82(3):274-284. doi: 10.1001/jamapsychiatry.2024.4216.
Mania/hypomania is the pathognomonic feature of bipolar disorder (BD). As BD is often misdiagnosed as major depressive disorder (MDD), replicable neural markers of mania/hypomania risk are needed for earlier BD diagnosis and pathophysiological treatment development.
To replicate the previously reported positive association between left ventrolateral prefrontal cortex (vlPFC) activity during reward expectancy (RE) and mania/hypomania risk, to explore the effect of MDD history on this association, and to compare RE-related left vlPFC activity in individuals with and at risk of BD.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study was conducted from July 2014 to December 2023 at the University of Pittsburgh, Pittsburgh, Pennsylvania. Three samples were formed comprising young adults (aged 18 to 30 years) without BD and with a range of subsyndromal-syndromal affective and anxiety psychopathologies, including a new sample and 2 test samples from our previous research; a sample of individuals aged 18 to 30 years with euthymic BD was also included. All participants were recruited from the community through advertising.
Functional magnetic resonance imaging during an RE task.
New sample: whole-brain activity during RE regressed to the Mood Spectrum Self-Report Lifetime Questionnaire (MOODS-SR-L) manic domain score in all participants and in those without history of MDD and RE-related whole-brain activity regressed to the MOODS-SR-L depressive domain score to determine specificity to mania/hypomania risk. Test samples: these associations were examined using parameter estimates of activity extracted from respective masks created from activity in the new sample. A tertile split of MOODS-SR-L manic domain score divided the new sample into 3 mania/hypomania risk groups. Comparison of RE-related activity (extracted parameter estimates) was performed in risk groups and individuals with BD.
Among the 113 individuals in the new sample, 73 were female, and the mean (SD) age was 23.88 (3.32) years. In each of the test samples, there were 52 individuals (39 female; mean [SD] age, 21.94 [2.12] years) and 65 individuals (47 female; mean [SD] age, 21.39 [2.11] years). The euthymic BD group had 37 individuals (30 female; mean [SD] age, 25.12 [3.81] years). In the new sample, 8 clusters of RE-related activity, including left vlPFC activity, showed a positive association with mania/hypomania risk, which remained after excluding individuals with MDD history and was specific to mania/hypomania risk. In the test samples, this association was shown in test sample 1 only (β, 0.21; 95% CI, 0.08-0.35; P = .002; q(false discovery rate [FDR]), 0.006; R2, 0.04). Test sample 2 had a higher proportion with MDD history (49 of 65 [75.3%] compared to 31 of 52 [59.6%] in sample 1). Combining individuals without history of MDD in both test samples replicated the association (β, 0.32; 95% CI, 0.08-0.58; P = .01; q[FDR], 0.023; R2, 0.02). RE-related left vlPFC activity was significantly greater in individuals at highest risk vs lowest (Cohen d, 1.01; 95% CI, 0.29-0.79; P < .001) and medium (Cohen d, 0.59; 95% CI, 0.12-0.63; P = .004) risk, as well as the euthymic BD group (Cohen d, 0.54; 95% CI, 0.07-0.58; P = .01), potentially due to medication effects.
Elevated RE-related left vlPFC activity was associated with mania/hypomania risk and attenuated by MDD history. These findings provide a neural target to help develop pathophysiological interventions for individuals with or at risk of mania/hypomania.
躁狂/轻躁狂是双相情感障碍(BD)的特征性表现。由于BD常被误诊为重度抑郁症(MDD),因此需要可重复的躁狂/轻躁狂风险神经标志物,以实现BD的早期诊断和病理生理学治疗的发展。
重复先前报道的奖励预期(RE)期间左侧腹外侧前额叶皮层(vlPFC)活动与躁狂/轻躁狂风险之间的正相关关系,探讨MDD病史对这种关联的影响,并比较BD患者和有BD风险个体中与RE相关的左侧vlPFC活动。
设计、设置和参与者:这项横断面研究于2014年7月至2023年12月在宾夕法尼亚州匹兹堡的匹兹堡大学进行。形成了三个样本,包括无BD的年轻成年人(18至30岁),他们具有一系列亚综合征-综合征性情感和焦虑心理病理学特征,包括一个新样本和我们先前研究中的2个测试样本;还纳入了18至30岁的心境正常的BD个体样本。所有参与者均通过广告从社区招募。
RE任务期间的功能磁共振成像。
新样本:将所有参与者以及无MDD病史者在RE期间的全脑活动回归到心境谱自我报告终生问卷(MOODS-SR-L)躁狂领域得分,并将与RE相关的全脑活动回归到MOODS-SR-L抑郁领域得分,以确定对躁狂/轻躁狂风险的特异性。测试样本:使用从新样本活动创建各自掩码中提取的活动参数估计值来检查这些关联。MOODS-SR-L躁狂领域得分的三分位数划分将新样本分为3个躁狂/轻躁狂风险组。在风险组和BD个体中进行与RE相关活动(提取的参数估计值)的比较。
新样本中的113名个体中,73名是女性,平均(标准差)年龄为23.88(3.32)岁。每个测试样本中分别有52名个体(39名女性;平均[标准差]年龄,21.94[2.12]岁)和65名个体(47名女性;平均[标准差]年龄,21.39[2.11]岁)。心境正常的BD组有37名个体(30名女性;平均[标准差]年龄,25.12[3.81]岁)。在新样本中,8个与RE相关的活动簇,包括左侧vlPFC活动,与躁狂/轻躁狂风险呈正相关,在排除有MDD病史的个体后仍然存在,并且对躁狂/轻躁狂风险具有特异性。在测试样本中,仅在测试样本1中显示了这种关联(β,0.21;95%CI,0.08 - 0.35;P = 0.002;q(错误发现率[FDR]),0.006;R2,0.04)。测试样本2中MDD病史的比例更高(65名中的49名[75.3%],而样本1中52名中的31名[59.6%])。将两个测试样本中无MDD病史的个体合并后重复了这种关联(β,0.32;95%CI,0.08 - 0.58;P = 0.01;q[FDR],0.023;R2,0.02)。与RE相关的左侧vlPFC活动在最高风险个体中显著高于最低(Cohen d,1.01;95%CI,0.29 - 0.79;P < 0.001)和中等(Cohen d,0.59;95%CI,0.12 - 0.63;P = 0.004)风险个体,以及心境正常的BD组(Cohen d,0.54;95%CI,0.07 - 0.58;P = 0.01),这可能是由于药物作用。
与RE相关的左侧vlPFC活动升高与躁狂/轻躁狂风险相关,并因MDD病史而减弱。这些发现为帮助开发针对躁狂/轻躁狂患者或有躁狂/轻躁狂风险个体的病理生理学干预措施提供了一个神经靶点。